David Rescott
Stock Analyst at Baird
(3.72)
# 782
Out of 4,667 analysts
41
Total ratings
61.29%
Success rate
5.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $96 → $93 | $84.69 | +9.81% | 3 | Nov 20, 2024 | |
| PEN Penumbra | Maintains: Outperform | $244 → $248 | $237.67 | +4.35% | 16 | Oct 31, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $107 → $109 | $105.05 | +3.76% | 2 | Oct 31, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $66 → $72 | $50.56 | +42.41% | 3 | Oct 31, 2024 | |
| NARI Inari Medical | Maintains: Outperform | $66 → $67 | $49.68 | +34.87% | 3 | Oct 29, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $73 → $68 | $70.12 | -3.02% | 3 | Oct 25, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $503 → $565 | $547.12 | +3.27% | 1 | Oct 18, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $90 → $91 | $91.38 | -0.42% | 4 | Jul 25, 2024 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $12.14 | +114.17% | 6 | Dec 22, 2023 |
Medtronic
Nov 20, 2024
Maintains: Neutral
Price Target: $96 → $93
Current: $84.69
Upside: +9.81%
Penumbra
Oct 31, 2024
Maintains: Outperform
Price Target: $244 → $248
Current: $237.67
Upside: +4.35%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $107 → $109
Current: $105.05
Upside: +3.76%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $66 → $72
Current: $50.56
Upside: +42.41%
Inari Medical
Oct 29, 2024
Maintains: Outperform
Price Target: $66 → $67
Current: $49.68
Upside: +34.87%
Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73 → $68
Current: $70.12
Upside: -3.02%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $503 → $565
Current: $547.12
Upside: +3.27%
Boston Scientific
Jul 25, 2024
Maintains: Outperform
Price Target: $90 → $91
Current: $91.38
Upside: -0.42%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $12.14
Upside: +114.17%